AwardedSpainGoods€35,000
suministro de los principios activos denominados "vacuna HEPATITIS B 20 mcg"; "vacuna MENINGOCOCO B"; "MOMELOTINIB 150 MG" Y"MOMELOTINIB 200 mg" para el Hospital Universitario de Gran Canaria Dr.Negrín.
- Published
- Published 4 June 2026
Overview
The Hospital Universitario de Gran Canaria Dr. Negrín procured active pharmaceutical ingredients comprising hepatitis B vaccine (20 mcg), meningococcal B vaccine, and momelotinib (150 mg and 200 mg formulations). The contract was awarded to GlaxoSmithKline, S.A. on 26 April 2026 for €109,997.90.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €35,000
- Procedure
- Direct
- Published
- 4 June 2026
Various medicinal products
Award outcome
- Awarded value
- €109,998
- Award date
- 26 April 2026
- GLAXOSMITHKLINE, S.A
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
4 June 2026
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.